Pharmacy - Pharmacoeconomics News & Articles

921 Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy Journal of Gastroenterology, April 22, 2009

922 A Hybrid Cohort Individual Sampling Natural History Model of Age-Related Macular Degeneration: Assessing the Cost-Effectiveness of Screening Using Probabilistic Calibration Medical Decision Making, April 20, 2009

923 Clinical Testing Patterns and Cost Implications of Variation in the Evaluation of CKD Among US Physicians American Journal of Kidney Diseases, April 17, 2009    Clinical Article

924 Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice International Journal of Technology Assessment in Health Care, April 17, 2009    Clinical Article

925 Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden International Journal of Technology Assessment in Health Care, April 17, 2009

926 Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan. PharmacoEconomics, April 16, 2009

927 Seroepidemiologic study of human cytomegalovirus in pregnant women in Valiasr Hospital of Kazeroon, Fars, Iran The Journal of Maternal-Fetal and Neonatal Medicine, April 16, 2009

928 Preferences of GPs and Patients for Preventive Osteoporosis Drug Treatment PharmacoEconomics, April 15, 2009

929 Atomoxetine's Effect on Societal Costs in Sweden Journal of Attention Disorders, April 15, 2009

930 The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone PharmacoEconomics, April 14, 2009

931 Costing and Cost Analysis in Randomized Controlled Trials PharmacoEconomics, April 13, 2009

932 Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium PharmacoEconomics, April 10, 2009

933 The Costs of Treating Breast Cancer in the US PharmacoEconomics, April 9, 2009

934 Cost of Illness of Glaucoma: A Critical and Systematic Review. PharmacoEconomics, April 8, 2009

935 Costs and Utility in Biomarker Use Full Text Applied Clinical Trials, April 8, 2009

936 Cost-analysis of school-based fluoride varnish and fluoride rinsing programs Acta Odontologica Scandinavica, April 7, 2009    Clinical Article

937 Selective laser photocoagulation versus serial amniodrainage for the treatment of twin-twin transfusion syndrome Journal of Perinatology, April 6, 2009

938 Public and private organizations join forces to help the uninsured connect to free or low-cost health services Full Text AstraZeneca, April 6, 2009

939 Allopathic Versus Homeopathic Strategies and the Recurrence of Prescriptions: Results from a Pharmacoeconomic Study in Italy Full Text Evidence-based Complementary and Alternative Medicine , April 3, 2009

940 Cost-Effectiveness Analysis of Anticoagulation Strategies in Non-ST-Elevation Acute Coronary Syndromes Annals of Pharmacotherapy, April 1, 2009

1 Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement Clinical Therapeutics, April 18, 2013    Review Article

2 The Economic Burden of Treatment-Resistant Depression Clinical Therapeutics, April 19, 2013

3 Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact Journal of Clinical Pharmacy and Therapeutics, April 10, 2013    Review Article

4 Review of Economics and Cost-Effectiveness Analyses of Anticoagulant Therapy for Stroke Prevention in Atrial Fibrillation in the US Annals of Pharmacotherapy, April 22, 2013    Review Article

5 Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous Thromboembolism Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 9, 2013

6 A systematic review and meta-analysis of pharmacist-led fee-for-services medication review British Journal of Clinical Pharmacology, April 24, 2013    Evidence Based Medicine    Review Article

7 Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation Clinical Cardiology, March 18, 2013    Free full text

8 Cost-effectiveness of deep brain stimulation in patients with Parkinsons disease Movement Disorders, April 29, 2013

9 Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany Clinical Research in Cardiology, March 27, 2013

10 Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer Annals of Oncology, March 26, 2013

11 The Cost-Effectiveness of Oral Direct Factor Xa Inhibitors Compared with Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement Surgery Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 29, 2013

12 Cost effectiveness analysis of elementary school-located vaccination against influenza-Results from a randomized controlled trial Vaccine , March 20, 2013

13 Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013 American Journal of Health-System Pharmacy, March 13, 2013    Review Article

14 Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies Bone Marrow Transplantation, April 16, 2013

15 Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations- A simulation of comparative cost-effectiveness British Journal of Cancer, April 15, 2013    Review Article

16 Systematic Review and Quality Assessment of Cost-Effectiveness Analysis of Pharmaceutical Therapies for Advanced Colorectal Cancer Annals of Pharmacotherapy, April 8, 2013    Evidence Based Medicine    Review Article

17 Cost analysis of adjuvant therapy with XELOX or FOLFOX4 for colon cancer Colorectal Disease, April 2, 2013

18 The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions Multiple Sclerosis Journal, April 22, 2009

19 Economic Evaluation of Fulvestrant 500 mg Versus Generic Nonsteroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer in the United Kingdom Clinical Therapeutics, March 26, 2013

20 Outcomes, Health Costs and Use of Antiplatelet Agents in 7,082 Patients Admitted for an Acute Coronary Syndrome Occurring in a Large Community Setting Cardiovascular Drugs and Therapy, March 28, 2013